News on KAP2.1B from BioPortfolio.com http://www.BioPortfolio.com Consolidated KAP2.1B news from BioPortfolio.com Tue, 09 Feb 2010 23:56:06 GMT en Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033653&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033653&THISHREF=http://c.moreover.com/click/here.pl%3fz2535307824%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Is hepatitis B virus genotype C independently associated with cirrhosis?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038364&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038364&THISHREF=http://c.moreover.com/click/here.pl%3fz2537581969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038364&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038364&THISHREF=http://c.moreover.com/click/here.pl%3fz2537581969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEurekAlert!: Entecavir (Baraclude) Improves Liver Function in Chronic Hepatitis B Patients with Decompensated Cirrhosishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032915&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032915&THISHREF=http://c.moreover.com/click/here.pl%3fz2534878653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032915&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032915&THISHREF=http://c.moreover.com/click/here.pl%3fz2534878653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHIV and Hepatitis.com: Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038439&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038439&THISHREF=http://c.moreover.com/click/here.pl%3fz2537609520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038439&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038439&THISHREF=http://c.moreover.com/click/here.pl%3fz2537609520%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAustralian NZ Journal of Public Health: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034368&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034368&THISHREF=http://c.moreover.com/click/here.pl%3fz2535741653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034368&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034368&THISHREF=http://c.moreover.com/click/here.pl%3fz2535741653%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEast Bay Business Journal: The first meiosis of resynthesized Brassica napus, a genome blenderhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033764&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033764&THISHREF=http://c.moreover.com/click/here.pl%3fz2535395078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033764&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033764&THISHREF=http://c.moreover.com/click/here.pl%3fz2535395078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew Phytologist: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033478&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033478&THISHREF=http://c.moreover.com/click/here.pl%3fz2535224682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033478&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033478&THISHREF=http://c.moreover.com/click/here.pl%3fz2535224682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWichita Business Journal: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033331&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033331&THISHREF=http://c.moreover.com/click/here.pl%3fz2535141935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033331&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033331&THISHREF=http://c.moreover.com/click/here.pl%3fz2535141935%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033291&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033291&THISHREF=http://c.moreover.com/click/here.pl%3fz2535106563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033291&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033291&THISHREF=http://c.moreover.com/click/here.pl%3fz2535106563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: Life Sciences: Recent findings in life sciences in children described by researchers from Safdarjung Hospitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033181&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033181&THISHREF=http://c.moreover.com/click/here.pl%3fz2535051551%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033181&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033181&THISHREF=http://c.moreover.com/click/here.pl%3fz2535051551%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033125&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033125&THISHREF=http://c.moreover.com/click/here.pl%3fz2535026659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033125&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033125&THISHREF=http://c.moreover.com/click/here.pl%3fz2535026659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032503&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032503&THISHREF=http://c.moreover.com/click/here.pl%3fz2534679923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032503&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032503&THISHREF=http://c.moreover.com/click/here.pl%3fz2534679923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Dynavax starts hepatitis B trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032358&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032358&THISHREF=http://c.moreover.com/click/here.pl%3fz2534622132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032358&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KAP2.1B&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032358&THISHREF=http://c.moreover.com/click/here.pl%3fz2534622132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: